PhD, Pharmacology and Toxicology
College of Pharmacy
Functional genomics; molecular biology of cancer; cancer pharmacology.
Dr. Futscher has been a critical addition to RFG1 and the SWEHSC as an expert in epigenetics. Dr. Futscher is providing epigenetic analyses in many collaborative studies including developmental toxicity studies (Lantz-RFG2 - lung; Camenisch-RFG1-heart), genetic susceptibility (Klimecki-RFG1), and bladder cancer(Gandolfi-RFG1). He has been included in the recently renewed Superfund Program and currently has an NCI/NIEHS grant on "epigenetic remodeling following arsenical exposure" with both Klimecki and Gandolfi as Co-Is. He has also been able to translate his studies to exposed populations using the IHSFC Core for recruiting and sampling. In addition, Dr. Futscher was the founding director of the Genomics Shared Service and is currently its Scientific Director.